The loss or alteration of the 9p21.3 chromosome region, mainly affecting the gene of cyclin-dependent kinase inhibitor 2A (CDKN2A), is highly associated with the formation of ccRCC originated metastatic lesions [9]. The gene discussed is CDKN2A; the disease is nonpapillary renal cell carcinoma.